<?xml version="1.0" encoding="UTF-8"?>
<ref id="R4">
 <label>4</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Vaddepally</surname>
    <given-names>RK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kharel</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Pandey</surname>
    <given-names>R</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence</article-title>. 
  <source>Cancers</source>
  <year>2020</year>;
  <volume>12</volume>:
  <elocation-id>738</elocation-id>. 
  <pub-id pub-id-type="doi">10.3390/cancers12030738</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32245016?>
 </mixed-citation>
</ref>
